General
The State of New Mexico should mandate insurance carriers within the state to cover
The State of New Mexico should mandate insurance carriers within the state to cover medications prescribed by physicians for stimulant use disorder that have shown to be effective, are still in trial, and have otherwise had an improved outcome in reducing the use of methamphetamines.
2022 Submitted Public Comment to the CDC Clinical Practice Guideline for Prescribing Opioids
Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - 04/21/2022
COVID-19 Vaccination Rule 3
COVID-19 Vaccination and Treatment During Pregnancy
COVID-19 Vaccination and Treatment During Pregnancy - 04-07-2022
Joint Statement on COVID-19 Vaccination and Treatment During Pregnancy - 04-06-2022
COVID-19 Therapeutics Update - 04/05/2022
COVID-19 Therapeutics Update: Sotrovimab Pause & Updated NIH Treatment Guidelines - 04-05-2022
COVID Therapeutics - Quick Reference for Prescribers - 04-05-2022
HAN Alert Pediatric Ingestion of Cannabis Products
HAN Alert COVID-19 2nd Booster Dose Guidance
All 2021 HAN Alerts
Registration Guide Dec 2016, Cipro Resistant Meningitidis - 08-06-2020, Remdesivir Update Guidance - 08-28 2020, COVID-19 Pre-Season - 09-11-2020, COVID-19 - 09-2020, COVID-19 - 01-16-2020, COVID-19 - 03-31-2020, COVID-19 -04-01-2020, COVID-19 - Directive Reporting Testing Data on Portal - 04-03-2020, COVID-19 - TB Testing Deferment - 04-44-2020, COVID-19 - 04-20-2020 , COVID-19 - 05-06-2020, COVID-19 - Menthol - 06-17-2020, COVID-19 - Antibody Testing - 07-02-2020, COVID-19 - NIH Summary - 07-28-2020, COVID-19 - Rapid Antigen Tests - 10-16-2020, COVID-19 - Crisis Staffing Tiers - 11-19-2020, COVID-19 - 12-03-2020, COVID-19 - Pfizer Vaccine Training Series For Clinicians, COVID-19 - 12-21-2020, COVID-19 - Phase 1 A - 12-21-2020 , COVID-19 - Releases Clinical Guidance Following VaST Technical Report - 06-25-2021, COVID-19 - 432 MIS-C Associated With COVID - 05-14-2020.Medical Cannabis Program - Program Update 03/22/2022
All 2021 HAN Alerts ( Except December)
Wound Botulizm - 01-12-2021, COVID-19 Non-Hospital Therapeutics Admin Application - 01-21-2021, Wound Botulism - 01-21-2021, COVID-19 Pediatric Covid Testing - 02-01-2021, Advisory Requirements For TB Testing Of HCW Resumes - 04-01-2021, COVID-19 Vaccine Eligibility - 06-04-2021, COVID-19 Pause in J&J Distribution - 04-13-2021, COVID-19 Third Dose FOr Immunocompromised - 04-16-2021, NMMAT Pfizer Vaccine Recommendation 12 Years and Older - 05-13-2021, COVID-19 VaST Technical Report - 06-24-2021, Sodium Citate Lab Tube Shortage - 06-06-2021, COVID-19 Vaccine Data Improvement - 06-13-2021, COVID-19 Clinical Guidance Myocarditis Following mRNA Vaccination - 06-25-2021, RSV Surveillance - 07-22-2021, COVID-19 No Boosters Yet - 08-03-2021, COVID-19 Invermectin Toxicity - 09-10-2021.December 2022 HAN Alerts
CDC 00438 - 12-17-2021, Shigella In Metro Homeless - 12-16-2021, COVID-19 Boosters for 16-17 - 12-09-2021, COVID-19 Evusheld - mAb - 12-08-2021, COVID-19 CDC 459 Varient Of Concern Identified - Omicron - 12-01-2021.MCAB Meeting Notice 03-22-2022
January 2022 HAN Alerts
Updated Guidance on Managing Healthcare Personnel with Infection or Exposure - 01-05-2022, CDC and FDA Update Indications for Pfizer-BioNTech COVID-19 Vaccine - 01-06-2022, Update on Omicron and COVID-19 Therapeutics - 01-07-2022, CDC and FDA Shorten Booster Interval for Moderna COVID-19 Vaccine - 01-10-2022, Public Health Order Enforcement to start 2/4/2022 of Up To Date Vaccination of Status - 01-14-2022, Therapeutics Update:Eligibility Criteria & Oral Antiviral & Monoclonal Antibody - 01-25-2022, Requirements on Electronic Death Certifications - 01-24-2022.February 2022 HAN Alerts
Guidance for immunocompromised - 02-15-2022 , COVID Therapeutics - Quick Reference for Prescribers - 02-16-2022, COVID-19 Therapeutics Update: Patient Eligibility Criteria & New COVID-19 Therapeutic - 02-16-2022, COVID -19 Dealth Risk Increases as the Number of Comorbid Conditions Increases - 02-16-2022, COVID -19 Dealth Risk for Select Age Groups and Comorbid Conditions - 02-16-2022, Update for Providers regarding COVID-19 & Immunocompromised Patients - 02-22-2022, COVID-19 Therapeutics Update: Evusheld - 02-28-2022.This is a list of provider names.
Current Advisory Council Members List